Navigation Links
Glass Lewis & Co. Recommends Renovis Shareholders Vote For Merger With Evotec
Date:4/22/2008

SOUTH SAN FRANCISCO, April 22 /PRNewswire-FirstCall/ -- Renovis, Inc. (Nasdaq: RNVS), today announced that Glass Lewis & Co., a leading proxy advisory firm, has joined ISS/Risk Metrics in recommending that Renovis stockholders vote "FOR" the merger agreement with Evotec AG (Frankfurt Stock Exchange: EVT) at the Special Stockholders Meeting scheduled for May 1, 2008. In the proposed merger, each share of Renovis common stock will be converted into the right to receive the equivalent of 1.0542 Evotec ordinary shares.

The Board of Directors of Renovis unanimously recommends that stockholders vote "FOR" the approval and adoption of the agreement and plan of merger, and the approval of the merger and related transactions as described in the proxy statement/prospectus.

The company encourages all stockholders to vote their shares promptly by phone, Internet, or by mailing their proxy card, and to contact MacKenzie Partners at 800/322-2885 or collect at 212/929-5500 if they have any questions or need any assistance in voting their shares.

About Renovis

Renovis is a biopharmaceutical company focused on the discovery and development of drugs for major medical needs in the areas of neurological and inflammatory diseases. The Company's proprietary research programs focus on the purinergic receptors, P2X3 and P2X7, for the potential treatment of pain and inflammatory diseases. In addition, Renovis has a worldwide collaboration and license agreement with Pfizer to research, develop and commercialize small molecule vanilloid receptor (VR1).

For additional information about the company, please visit http://www.renovis.com.

Forward-Looking Statements

This c
'/>"/>

SOURCE Renovis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Fluorescent glass SRMs are new tool for spectroscopy
2. RiskMetrics Group (ISS) and Glass Lewis & Co. Support Nabi Biopharmaceuticals Proposed Asset Sale
3. Glass Lewis Recommends Datascope Shareholders Vote for Re-Election of the Boards Directors
4. Collaboration yields the right glasses for observing mystery behavior in electrons
5. UCT Specialties (Formerly Petrarch) Announces the Release of Their New Product Guides for Silanes, Silicones, Platinum Catalyst and Glass Coatings
6. Carbon nanotubes made into conductive, flexible stained glass
7. Report recommends off-site disposal of secondary waste
8. The International Diabetes Federation (IDF) Recommends Tighter Control of Blood Glucose Levels After Meals in People With Diabetes
9. Report recommends off-site disposal of secondary waste
10. GlaxoSmithKline Consumer Healthcare Recommends Maintaining FDAS Current Two-Class Drug System
11. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...Newswire/ -- BioTrends Research Group, Inc.,releas...M) publication, a,syndicated report offering compr...ia and bone and mineral metabolism in Chronic Kidn... information from 182 US,Nephrologists -- data wer...ne 2008., In the renal anemia market, while the u...
(Date:7/25/2008)...X, CALGARY, July 25 / Resv...X:RVX) is pleased to announce effective,immediatel...irectors. On,the subject of her appointment Jan Gr...xciting opportunity for me. The Company has done a...linical trials. I expect the next,foreseeable futu...
(Date:7/25/2008)...swire-FirstCall/ -- Caraco Pharmaceutical,Laborato...first quarter of,Fiscal 2009, ended June 30, 2008,...or the corresponding period of Fiscal 2008. This r...er of Fiscal 2008. Pre-tax income grew,to $14.6 mi...ared to a,pre-tax income of $9.6 million during th...
(Date:7/25/2008)...25 /- REvolution Computing will,lead ...R product at the,upcoming BioC 2008 conference in ... REvolution Computing Director of Community, Dr. D... Training Manager, and Martin Morgan of,the Fred H...ting,s BioC lab,will introduce participants to the...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Jan Gray Joins Resverlogix Board of Directors 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008 2
...its of switching to voice over Internet protocol (...at the Italian Community Center in Milwaukee. Near... users share their experiences with VoIP. , ,Clear...erry Rocco, Cisco Systems, and Pat Scheckel, VoIP ...Brian Carlson, manager network/communications for ...
...ence faculty at the University of Wisconsin-Eau Cl...h more opportunities to work on research relating ...e university to assist local industries. , ,UW-Eau...ll support research, facilitate collaboration amon...ractions between the university and local industri...
...Julius truly cares about me. He often sends me sto...as for how to buy prescription drugs on the cheap....duction. Ursula seems more interested in enlargeme...up in the From line of my e-mail every day, usuall...in the morning is cleaning out unsolicited message...
...roadcast Systems and Madison-based MyWeather LLC...tion that alerts for breaking news and severe weat...ated television stations. , ,Powered by MyWeather ...imely information to people while they are at work... Desktop Alert to proactively grab viewers attenti...
Other Biology Technology:VoIP: Are we there yet? 2UW-Eau Claire creates Materials Science Center 2UW-Eau Claire creates Materials Science Center 3Putting spam back in the can wont be all that easy 2
(Date:7/24/2008)...tate University College of Medicine, Hershey, Penn...uimod, a clinically important immune response modi... is dependent on the Opioid Growth Factor (OGF)-OG...very, reported in the August 08 issue of Experime...into a widely used drug that may lead to developme...
(Date:7/24/2008)... talk, they might tell potential suitors, "I like ...come slither look. But worms send their valentines...al code researchers are now cracking, according to...nal Nature . , Scientists from the University ...titute of Technology and the U.S. Department of Ag...
(Date:7/24/2008)...uced carbon storage in western U.S. forests , A...entury has caused a widespread increase in fire-in...stems growing on trees within western U.S. forests...re thought to account for much of North America,s ...ound biomass, Fellows and Goulden compare Californ...
(Date:7/23/2008)...together internationally renowned scientists from ...apan, Australia and India to address ancient micr...e are bringing together the world,s best scientist...izer J. William Schopf, founder and director of th...cs, Center for the Study of Evolution and the Orig...
Breaking Biology News(10 mins):Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Mate or hibernate? That's the question worm pheromones answer 2Mate or hibernate? That's the question worm pheromones answer 3AGU journal highlights -- July 23, 2008 2AGU journal highlights -- July 23, 2008 3AGU journal highlights -- July 23, 2008 4AGU journal highlights -- July 23, 2008 5AGU journal highlights -- July 23, 2008 6AGU journal highlights -- July 23, 2008 7AGU journal highlights -- July 23, 2008 8UCLA 'world summit' to explore ancient life on Earth, and beyond 2King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 1King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 2King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 3King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 4King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 5King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 6Once Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head to Head Study 5059 1Once Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head to Head Study 5059 2Once Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head to Head Study 5059 3Once Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head to Head Study 5059 4Once Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head to Head Study 5059 5Once Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head to Head Study 5059 6Once Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head to Head Study 5059 7Once Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head to Head Study 5059 8Amylin Pharmaceuticals to Webcast Conference Call 5055 1Amylin Pharmaceuticals to Webcast Conference Call 5055 2Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman 26 Renshaw Healthcare Conference 1603 1Anadys Pharmaceuticals to Present at the Acumen BioFin Rodman 26 Renshaw Healthcare Conference 1603 2
...s has,found the first clear evidence that the proc...ility to recognize and respond to a million,differ...f genes whose,only apparent function is to jump ar...ially cut themselves out of the genetic material, ...ght have been borrowed by cells,needing to build m...
...or of Research at the Molecular Sciences Institut... approach to simulation of intracellular,biochemic...Biotechnology.,The research article, entitled "Au...ith Moleculizer 1.0" (pdf) ,describes MSI,s discre...f the thousands of complex species formed from pat...
...em the rising rate of HIV infection, warn two seni...An estimated 38 million people worldwide, includin...IV, and a record 4.8 million became infected in 20...ncrease is socioeconomic, but the increase also re...s. , For instance, the search for a vaccine agains...
...al nervous system (CNS), where it influences neuro...an now use microarray technology to study brain fu...ed in the February issue of Alcoholism: Clinical &...alcohol on what is called "gene expression" in the... have exactly the same deoxyribonucleic acid (DNA)...
Other Biology News:Jumping gene helps explain immune system's abilities 2Jumping gene helps explain immune system's abilities 3MSI releases 'moleculizer' - a new approach to simulation of intracellular biochemical networks 2MSI releases 'moleculizer' - a new approach to simulation of intracellular biochemical networks 3Alcohol's effects on gene expression in the central nervous system 2Alcohol's effects on gene expression in the central nervous system 3Alcohol's effects on gene expression in the central nervous system 4
The epitope recognized by A300-183A maps to the C-terminus of isoform 5 of human quaking homolog according to entry AAH19917.1 (GeneID 9444). The epitope is not found in isoforms 1, 2, 3, 4, 6, 7 or
... ml Dynabeads Epoxy (4.5 m). Hydrophobic naked be...deal for coupling of antibodies for cell applicati...ial coupling with covalent binding of primary amin...ring within 16-20 hours. Coupling reactions can be...
Flotillin-2 (ESA) Purified Anti-Mouse, Anti-Rat, Anti-Human, Anti-Dog, Anti-Chicken clone 29, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details.
St. Louis encephalitis Immunogen: St. Louis encephalitis. Storage: -20 C, Avoid Freeze/Thaw Cycles
Biology Products: